top of page

NEW UPDATE: *Change in process for outpatient COVID-19 management*

To MUHC users: Please note that as of Dec 5, 2022, requests for outpatient antiviral management of COVID-19 for HIGH RISK patients should be directed to the ID-AMB (formerly MicroB/Lachine) service rather than ID-HOT. If a patient is a potential candidate for outpatient antiviral therapy but a delay is anticipated before they can be seen by Medical Day (eg. present to ED on a friday afternoon, weekend etc), please ensure that the antiviral is started in ED to ensure there are no delays in treatment! Prophylactic Evusheld should be offered to high-risk patients (see criteria) if > 6 months since their last dose.

32 views0 comments

Recent Posts

See All

The ASP committee updated the COVID guidelines. You will find the following change: -Removal of the pre-exposure prophylaxis guidelines since monoclonal antibodies are no longer easly available. -Clar

bottom of page